Back
Novo Nordisk AS Stock Predictions
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Sell
27
NONOF
Novo Nordisk AS
Last Price:
106.21
Seasonality Move:
9.66%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!Novo Nordisk AS Stock Forecast
- Over the next 52 weeks, Novo Nordisk AS has on average historically risen by 25.3% based on the past 16 years of stock performance.
- Novo Nordisk AS has risen higher in 13 of those 16 years over the subsequent 52-week period, corresponding to a historical accuracy of 81.25%
-
Is Novo Nordisk AS Stock Undervalued?
The current Novo Nordisk AS [NONOF] share price is $106.21. The Score for NONOF is 27, which is 46% below its historic median score of 50, and infers higher risk than normal. - NONOF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Novo Nordisk AS Stock Go Up Next Year?
- Over the next 52 weeks, Novo Nordisk AS has on average historically risen by 25.3% based on the past 16 years of stock performance.
Novo Nordisk AS Stock Rating
Sell
27
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS overpriced?
- Novo Nordisk AS has risen higher in 13 of those 16 years over the subsequent 52-week period, corresponding to a historical accuracy of 81.25%
Novo Nordisk AS Stock Price History
Stock Information
Stock Info
Exchange:
OTCM
Country:
Denmark
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
novonordisk.com
52-Week Data
52-Week High:
149.55
52-Week Low:
93.80
Prediction Charts
Market Cap:
472.63B
Price in USD:
106.21
Volume:
35.28K
Beta:
0.51
Technical Analysis
SMA50:
123.26
SMA100:
129.91
SMA200:
128.08
52-Wk Change:
8.8%
Stock Predictions
-
Is Novo Nordisk AS stock public?
Yes, Novo Nordisk AS is a publicly traded company. -
What is the Novo Nordisk AS stock quote today?
The Novo Nordisk AS stock price is 106.21 USD today. -
How to buy Novo Nordisk AS stock online?
You can buy Novo Nordisk AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Oct-16 | 117.90 | 116.26 | 120.60 | 116.26 |
| Oct-18 | 120.15 | 117.50 | 120.53 | 115.70 |
| Oct-21 | 120.15 | 119.13 | 120.25 | 115.78 |
| Oct-22 | 115.05 | 117.00 | 118.50 | 112.90 |
| Oct-23 | 117.54 | 114.22 | 117.54 | 112.02 |
| Oct-24 | 115.00 | 116.00 | 117.58 | 112.00 |
| Oct-25 | 115.20 | 115.20 | 115.20 | 112.00 |
| Oct-28 | 116.75 | 113.15 | 116.75 | 111.13 |
| Oct-29 | 115.65 | 110.75 | 115.65 | 109.53 |
| Oct-30 | 112.70 | 110.80 | 114.00 | 105.98 |
| Oct-31 | 110.80 | 109.00 | 113.03 | 105.90 |
| Nov-1 | 115.29 | 111.54 | 115.29 | 109.00 |
| Nov-4 | 114.55 | 109.80 | 114.55 | 107.79 |
| Nov-5 | 110.48 | 106.21 | 112.15 | 105.00 |
Novo Nordisk AS Earnings
Novo Nordisk AS Earnings Report: Per Share Novo Nordisk AS Earnings Q1 Q2 Q3 and Q4 last year and next year.
Novo Nordisk AS Forecast Revenue Growth
Novo Nordisk AS Stock Analysis: Historical quarterly revenues per share for Novo Nordisk AS and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.
* Novo Nordisk AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.